Abstract:Several factors can affect drug release from polylactide coglycolide (PLGA)-based formulations, including polymer and drug properties, formulation components, manufacturing processes, and environmental in vitro or in vivo conditions. To achieve optimal release profiles for specific drug delivery applications, it is crucial to understand the mechanistic processes that determine drug release from PLGA-based formulations. In the current study, we developed a mechanistic model for the in vitro drug release of PLGA-based solid implants. The model accounts for all known critical quality attributes (CQAs) and considers the most important release rate processes, including water or dissolution medium influx into the porous structure of the implant, initial noncatalytic hydrolysis of PLGA, autocatalytic hydrolysis, dissolution of oligomers and monomers into the aqueous medium, the liberation of the trapped solid drug from the polymer matrix, dissolution of the solid drug into the wetted pore network, diffusion of the dissolved drug out of the implant, and distribution of the dissolved drug into the dissolution medium. The model has been validated using in vitro release data obtained from implants of four drugs (buserelin, afamelanotide, brimonidine, and nafarelin). The model presented in this manuscript provides valuable insights into the kinetics and mechanism of drug release from PLGA-based solid implants and has demonstrated the potential for optimizing formulation design. The in vitro release model, coupled with physiologically based pharmacokinetic (PBPK) modeling, can predict the in vivo performance of implants and can be used to support bioequivalence studies in a drug development program.

Modeling and Simulation of the Drug Release from PLGA Drug Delivery Micro-system Based on Monte Carlo model

Modeling and Simulation of Drug Release from Implantable PLGA Drug Delivery System

Modeling and Optimization of Drug Release from Diffusion-Controlled Spherical Devices

Modeling of in vitro drug release from polymeric microparticle carriers

Modeling and Simulation of Drug Delivery from a New Type of Biodegradable Polymer Micro-Device

Modeling and Simulation of Drug Release from Multi-Layer Biodegradable Polymer Microstructure in Three Dimensions.

Design of Controlled Drug Delivery System with Optimal Release Characteristics

Modeling the drug release from 3D multi-layer microstructure with micro-chambers

Decoration and Application of PLGA Microspheres

Numerical modeling of a novel degradable drug delivery system with microholes

New Model and Simulation for Biodegradable Controlled Drug Delivery System Based on CA

Study on structural optimum design of implantable drug delivery micro-system

The 3-Dimensional Simulation Of A Novel Degradable Implantable Controlled Drug Delivery

A dissolution-diffusion model and quantitative analysis of drug controlled release from biodegradable polymer microspheres

The Optimization Design of a Novel Biodegradable Polymer Micro-Device

Dynamic Modeling of Controlled Drug Release Performance in Polymer Microspheres

Structure-Property Relationships and Models of Controlled Drug Delivery of Biodegradable Poly (D, L-lactic Acid) Microspheres

Mechanistic Model for Drug Release from PLGA-Based Biodegradable Implants for In Vitro Release Testing: Development and Validation

Study of Release Traits of Subminiature Controlled Drug Release System Based on MEMS

Characterizing the drug release from the hydrogel drug delivery system incorporated with biodegradable microspheres

Effect of Degradable Polymer Swelling Property on Release Performance of Controlled Drug Delivery System